Alcon completes acquisition of aerie pharmaceuticals, inc., strengthening company's ophthalmic pharmaceutical business

Geneva--( business wire )--alcon (six/nyse: alc), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of aerie pharmaceuticals, inc. (nasdaq: aeri, “aerie”). this transaction helps bolster alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
ALC Ratings Summary
ALC Quant Ranking